Palbociclib

Palbociclib is a small molecule which can act as a CDK4 / CDK6 inhibitor. It is provided as a powder.

This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Autophagy, Glycation, Cell cycle, Senescence, Carbohydrate metabolism.
This product may be of interest in the following research areas and diseases: Immunology, Cell death, Cancer, Diabetes.
This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV in silico, probably through blocking the main protease, Mpro (3CLpro, Nsp5).

Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.

Solubility: 2 mg/ml in warm DMSO.

Target	Palbociclib
Form	Solid
Purity	> 98% (TLC). Conforms to structure by NMR.
Reconstitution	Soluble in DMSO (up to 2 mg/ml with warming)
Storage	Store desiccated at -20 °C. Solutions can be stored at -20 °C for up to 1 month.
Molecular Weight	447.5 g/mol
Molecular Formula	C24H29N7O2
Buffer	Not applicable.
CAS Number	571190-30-2
Availability	Shipped within 5-10 working days.
Note	This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Research Articles on Palbociclib

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue